More Business Wire
View Older Stories View Newer Stories-
Equillium Maintains Rights to Itolizumab Following Ono Partnership
-
Noridian and HTG Join Forces to Ease the Medicaid Provider Enrollment Experience and Improve Access to Care
-
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results
-
Thetis Pharmaceuticals Announces Positive Initial Results From Phase 1a Study of TP-317 in Healthy Subjects
-
Ventus Therapeutics Announces Successful Completion of Phase 1 Clinical Trial of VENT-03, a First-in-Class, Orally Administered cGAS Inhibitor
-
Largo to Release its Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
-
BostonGene to Showcase Innovative Precision Medicine Strategies for Non-Small Cell Lung Cancer at the Advancing Precision Medicine Conference 2024
-
Bristol Myers Squibb Reports Third Quarter Financial Results for 2024
-
Xylem Reports Third Quarter 2024 Results and Narrows Full-Year Guidance
-
Uber Announces Results for Third Quarter 2024
-
Green Plains Reports Third Quarter 2024 Financial Results
-
Trinity Industries, Inc. Announces Third Quarter 2024 Results
-
Hyatt Reports Third Quarter 2024 Results
-
Ryder Receives Supplier-of-the-Year Award from Toyota
-
AECOM selected for a $90 million single-award task order for the G7 Partnership for Global Infrastructure and Investment
-
SunCoke Energy, Inc. Declares Cash Dividend
-
Kontoor Brands Reports 2024 Third Quarter Results; Raises Full Year Outlook
-
Green Plains Appoints Phil Boggs as Chief Financial Officer, Jim Stark to Retire From Green Plains
-
Aptiv Reports Third Quarter 2024 Financial Results
-
RPM Acquires TMP Convert to Expand Decking and Landscaping Offerings
-
Personalized Neuromodulation Treatment Significantly Slowed Alzheimer’s Progression in 12-month Phase 2 Study, Meeting Primary and Key Secondary Endpoints
-
Granite Reports Third Quarter 2024 Results
-
1-800-FLOWERS.COM, Inc. Reports Fiscal 2025 First Quarter Results
-
Vista Gold Phase 2 Drilling Continues to Intercept High Grade Gold Mineralized Intervals in the South Cross Lode at Mt Todd
-
MarineMax Reports Fiscal 2024 Fourth Quarter and Full Year Results
-
The Estée Lauder Companies Inc. Declares Quarterly Dividend of $.35 Per Share
-
HF Sinclair Corporation Reports 2024 Third Quarter Results and Announces Regular Cash Dividend
-
The Estée Lauder Companies Reports Fiscal 2025 First Quarter Results
-
Eaton Reports Record Third Quarter 2024 Results, with Accelerating Orders and Continued Backlog Growth
-
IDEXX Laboratories Announces Third Quarter Results
-
IDACORP, Inc. Announces Third Quarter 2024 Results, Increases Lower-End of Earnings Guidance Range
-
Mobileye Releases Third Quarter 2024 Results and Provides Business Overview
-
Utz Brands Reports Third Quarter 2024 Results and Reaffirms 2024 Outlook
-
Spectrum Brands Holdings to Report Fiscal 2024 Fourth Quarter Financial Results and Hold Conference Call and Webcast on November 15, 2024
-
Lazard Reports Third-Quarter and Nine-Month 2024 Results
-
Merck Announces Third-Quarter 2024 Financial Results
-
Cinemark Holdings, Inc. Reports Third Quarter 2024 Results
-
Vontier Reports Strong Third Quarter 2024 Results and Narrows Full Year Guidance
-
Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates
-
Give Thanks for Free Turkeys! BJ’s Wholesale Club Delivers Unbeatable Value with Annual Turkey Promotion
-
Babcock & Wilcox Announces Closing of Previously Announced Sale of its Italian and Swedish Businesses
-
InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024
-
Xcel Energy Third Quarter 2024 Earnings Report
-
Genesis Energy, L.P. Reports Third Quarter 2024 Results
-
Lincoln Financial Reports 2024 Third Quarter Results
-
Dorian LPG Ltd. Announces Second Quarter Fiscal Year 2025 Financial Results
-
Fresh Del Monte Produce Inc. Reports Third Quarter Earnings for Fiscal 2024
-
Silobreaker Named as a G-Cloud 14 Supplier
-
Li-Cycle and Glencore Establish Commercial Framework for Rochester Hub Products
-
AiCuris Initiates First-in-Human Phase 1 Trial With Antiviral Agent AIC468 to Address BK Virus Infections in Kidney Transplant Recipients
